Bio-Path Holdings, Inc. (BPTH) Reports First Quarter 2013 Operational and Financial Results
5/16/2013 10:11:50 AM
More...
|
Bio-Path Holdings, Inc. (BPTH) Reports Fiscal Year 2012 Operational and Financial Results
4/3/2013 6:22:04 AM
More...
|
Bio-Path Holdings, Inc. (BPTH) Begins Enrollment in Fifth Cohort of Phase I Clinical Trial of Lead Product Candidate Liposomal Grb-2 in Leukemias
3/8/2013 8:55:43 AM
More...
|
Bio-Path Holdings, Inc. (BPTH) to Present at the Biotech Showcase 2013 Conference
1/3/2013 8:43:43 AM
More...
|
Bio-Path Holdings, Inc. (BPTH) to Expand Development of Liposomal Grb-2 Into Two Additional Indications: Triple Negative and Inflammatory Breast Cancers
12/6/2012 11:05:14 AM
More...
|
Bio-Path Holdings, Inc. (BPTH) Reports Third Quarter 2012 Operational and Financial Results
11/16/2012 9:26:29 AM
More...
|
Bio-Path Holdings, Inc. (BPTH) Adds New Board Member
10/4/2012 10:17:54 AM
More...
|
Bio-Path Holdings, Inc. (BPTH) to Present at the 11th Annual Biotechnology Industry Organization (BIO) Investor Forum
10/3/2012 10:01:13 AM
More...
|
Bio-Path Holdings, Inc. (BPTH) to Present at the Rodman & Renshaw Annual Global Investment Conference
9/4/2012 10:44:37 AM
More...
|
Bio-Path Holdings, Inc. (BPTH) to Present at the 2012 Southern California Investor Conference
8/23/2012 4:47:59 PM
More...
|
|